R Golder - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R Golder

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Nature Biomedical Engineering|April 25, 2019

Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.

Nature Biomedical Engineering|March 29, 2019

Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.

Journal of the American Chemical Society|March 19, 2021

Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Nature Biomedical Engineering|April 25, 2019

Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.

Nature Biomedical Engineering|March 29, 2019

Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugsMatthew R Golder, Jenny Liu, Jannik N Andersen, et al.

Journal of the American Chemical Society|March 19, 2021

Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.

Pageof 4